1994
DOI: 10.1042/cs045015pa_pt2
|View full text |Cite
|
Sign up to set email alerts
|

Measurement of Sugar Probes in Serum, and Their Application in the Assessment of Intestinal Permeability

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
11
2

Year Published

1999
1999
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(14 citation statements)
references
References 0 publications
1
11
2
Order By: Relevance
“…The fact that the 5 h cumulative lactulose excretion reported in one study of subjects with frank coeliac disease was lower than those in our studies and their mannitol excretions higher giving LMRs of 0.146 [42] and 0.018 [40] is further testament to the variability of the LMR and the variability of the excretion of component sugars with differing inflammatory stimuli. These examples likely indicate that inflammation from a disease and from a pro-inflammatory stimulus such as aspirin can have differing outcomes that may be better identified by comparisons based on the temporal profiles of the two probes rather than the ratios of cumulative excretion.…”
Section: Discussioncontrasting
confidence: 65%
See 1 more Smart Citation
“…The fact that the 5 h cumulative lactulose excretion reported in one study of subjects with frank coeliac disease was lower than those in our studies and their mannitol excretions higher giving LMRs of 0.146 [42] and 0.018 [40] is further testament to the variability of the LMR and the variability of the excretion of component sugars with differing inflammatory stimuli. These examples likely indicate that inflammation from a disease and from a pro-inflammatory stimulus such as aspirin can have differing outcomes that may be better identified by comparisons based on the temporal profiles of the two probes rather than the ratios of cumulative excretion.…”
Section: Discussioncontrasting
confidence: 65%
“…To assess whether any differences in the cumulative recoveries of each sugar could influence the LMR in healthy individuals and in patients with IBDs, we compared the results of our work with those of published studies on subjects with Coeliac or Crohn’s disease [40][42] that employed similar protocols and doses of lactulose and mannitol. We determined cumulative recoveries over a 5 h period for each sugar, both after dosage with placebo and after dosage with aspirin, to allow meaningful comparisons with the five hour recoveries reported in these studies.…”
Section: Methodsmentioning
confidence: 99%
“…L : M values discriminated well between subjects with normal biopsy and those with villous atrophy. Fleming et al (1996) successfully measured L and M by HPLC in serum 90 min after intake, while other workers have used automated enzymic assays (Lunn et al 1989;Northrop et al 1990). The HPLC results agree well with L : M values determined enzymically following a 5 h urine collection (r 0·88, P = 0·05), hence the two methods can be used interchangeably.…”
Section: Gastrointestinal Tractsupporting
confidence: 64%
“…Simultaneous use of sucrose and lactulose/mannitol probes allows non-invasive detection of gastric and enteric damage, respectively (Meddings and Gibbons, 1998). The plasma (or serum) ratio between orally administered disaccharide lactulose and monosaccharide mannitol expressed as the lactulose/mannitol (L/M) index may be used as the indicator of intestinal permeability (Fleming et al, 1996;Van der Hulst et al, 1998;Bruet et al, 2008). Intestinal permeability increases with increasing L/M index.…”
Section: Resultsmentioning
confidence: 99%
“…The administration of site specific permeability probes, such as monosaccharides and disaccharides, to detect permeability defects at different levels of the gastrointestinal tract represent a single screening test for assessment of the functional integrity of the gastrointestinal mucosa (Meddings and Gibbons, 1998). One or more sugar probes are given orally and the excretion of the probe(s) is than measured in the urine, plasma or serum (Meddings et al, 1993;Bijlsma et al, 1995;Van Elburg et al, 1995;Fleming et al, 1996;Cox et al, 1997;Sorensen et al, 1997;Johnston et al, 2000;Uil et al, 2000;Smecuol et al, 2001;Craven et al, 2007).…”
Section: Introductionmentioning
confidence: 99%